4Vote!
Radon Mitigation Pittsburgh (Free subscription) | 11/05/2009
( EMAILWIRE.COM , November 05, 2009 ) Dallas, TX - Charles River Laboratories (NYSE:CRL) was one of the most active losers in todays trading session as it plunged over 8.17% to $34.07 on a volume of 2.97 million shares after the company yesterday reported its results for the third quarter of 2009. For the quarter, net sales were $297.5 million, a decline of 13.1% from $342.2 million in the third quarter...
5Vote!
Market Wire (Free subscription) | 11/04/2009
NEW DELHI, INDIA (MARKET WIRE) Wallstsense.com is an online community with a dedicated team of analysts who are providing free in-depth research on North American equities. Our analysts have issued complimentary analysis on the following six companies: Kansas City Southern (NYSE: KSU), Allied Capital Corporation (NYSE: ALD), KB Home (NYSE: KBH), J. Crew Group Inc. (NYSE: JCG), Charles River Laboratories...
5Vote!
Stocks to Watch Today (Free subscription) | 11/03/2009
Pharma services firm Charles River Laboratories (CRL) shares are taking it hard this evening, falling $2.10, or 6%, to $35, after the company missed Q3 sales estimates and gave a wearker-than-expected outlook for the year’s profit. Revenue fell 13%, year over year, to $297.5 million and missed the $307 million [...]
4Vote!
Business Wire (Free subscription) | 11/03/2009
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2009. For the quarter, net sales were $297.5 million, a decline of 13.1% from $342.2 million in the third quarter of 2008, primarily driven by lower sales in the Preclinical Services (PCS) segment. Foreign currency translation reduced net sales by 1.8%....
4Vote!
Contract Pharma Breaking News (Free subscription) | 10/19/2009
Charles River Laboratories has laid off 115 workers from its CTBR Bio-Research unit near Montreal. The company laid off 140 employees from CTBR in May 2006. After this round of layoffs, CTBR will have approximately 1,480 employees. In an e-mail to The Montreal Gazette , CRL spokeswoman Amy Cianciaruso remarked, "Like others in our industry, Charles River has been affected by this slowdown and...
4Vote!
Xconomy (Free subscription) | 10/17/2009
Wilmington, MA-based Charles River Laboratories (NYSE: CRL) has eliminated 115 positions at subsidiary CTBR Bio-Research in Senneville, Quebec, according to an article yesterday in the Montreal Gazette. A spokesperson quoted in the article attributed the cuts to the postponement of contract clinical research and development projects by the company’s pharmaceutical-industry clients. It’s...
4Vote!
Business Wire (Free subscription) | 10/07/2009
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories, Inc. (NYSE: CRL), today announced the Company’s new Shanghai facility received accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), the Canadian Council on Animal Care (CCAC) and the Shanghai Laboratory Animal Commission (SLAC). The AAALAC, CCAC and SLAC accreditations confirm Charles...
5Vote!
Business Wire (Free subscription) | 10/06/2009
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2009 financial results on Tuesday, November 3rd, after the market closes. A conference call has been scheduled to discuss the results on Wednesday, November 4th, at 8:30 a.m. ET. Investors will have the opportunity to listen to a live webcast of the conference call through the Investor...
4Vote!
Radon Mitigation Pittsburgh (Free subscription) | 09/25/2009
( EMAILWIRE.COM , September 24, 2009 ) DALLAS, Texas - StockPreacher.com announces an investment report featuring pharmaceutical company WuXi PharmaTech (Cayman) Inc. (NYSE: WX). The investment report on WuXi PharmaTech (Cayman) Inc. (NYSE: WX) should be of particular interest to other pharmaceutical companies: Covance Inc. (NYSE: CVD), Charles River Laboratories International Inc. (NYSE: CRL), ICON...
4Vote!
Business Wire (Free subscription) | 09/14/2009
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Morgan Stanley Global Health Care Conference in New York on Tuesday, September 15th, at 10:20 a.m. ET and the UBS Global Life Sciences Conference in New York on Tuesday, September 22nd at 2:00 p.m. ET. Management will present an overview of Charles River’s...
3Vote!
Navivest Stocks and Options Blog (Free subscription) | 09/12/2009
Friday September 11, 2009 Navivest Charles River Laboratories International (CRL) has seen its shares bounce nicely off the $34 area a week ago to rally up to $36.88. The stock is trading... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Videos